We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+29.53%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
AUM
$2.33B
AUM Growth
+$652M
Cap. Flow
+$196M
Cap. Flow %
8.41%
Top 10 Hldgs %
83.2%
Holding
28
New
8
Increased
3
Reduced
7
Closed
5

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$126M
2
NWSA icon
News Corp Class A
NWSA
+$44.6M
3
KROS icon
Keros Therapeutics
KROS
+$33.1M
4
AIV
Aimco
AIV
+$28.7M
5
CTRI icon
Centuri Holdings
CTRI
+$14.7M

Sector Composition

Rank Sector Weight
1 Healthcare 42.5%
2 Technology 14.85%
3 Industrials 14.12%
4 Consumer Staples 9.67%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNDK
1
Sandisk
SNDK
$213B
$340M 14.63%
1,434,172
-628,349
-30% -$126M
GHC icon
2
Graham Holdings Company
GHC
$4.97B
$270M 11.6%
245,829
GMED icon
3
Globus Medical
GMED
$10.4B
$229M 9.85%
2,624,751
+76,588
+3% +$5.81M
INDV icon
4
Indivior Pharmaceuticals
INDV
$4.79B
$225M 9.68%
6,280,502
-183,083
-3% -$5.59M
MKL icon
5
Markel Group
MKL
$25B
$189M 8.12%
87,889
+3,579
+4% +$7.25M
TBPH icon
6
Theravance Biopharma
TBPH
$874M
$178M 7.65%
9,511,150
SOLV icon
7
Solventum
SOLV
$13.5B
$158M 6.77%
1,988,058
-318
-0% -$24.4K
SOLS
8
Solstice Advanced Materials
SOLS
$9.62B
$135M 5.81%
+2,782,460
New +$131M
MOH icon
9
Molina Healthcare
MOH
$10.3B
$110M 4.73%
+633,877
New +$104M
MICC
10
The Magnum Ice Cream Company N.V.
MICC
$10.9B
$102M 4.38%
+6,429,296
New +$101M
LKFT
11
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$72.4M 3.11%
2,213,169
+17,394
+0.8% +$562K
BTI icon
12
British American Tobacco
BTI
$132B
$69.3M 2.98%
1,223,767
UNF icon
13
Unifirst Corp
UNF
$5.32B
$58.6M 2.52%
+303,844
New +$51.3M
STGW icon
14
Stagwell
STGW
$1.84B
$39.2M 1.68%
8,014,322
WLY icon
15
John Wiley & Sons Class A
WLY
$2.52B
$35.1M 1.51%
1,147,258
-23,366
-2% -$823K
MAGN
16
Magnera Corp
MAGN
$488M
$27M 1.16%
1,780,649
-1,051,632
-37% -$12.2M
TPB icon
17
Turning Point Brands
TPB
$1.47B
$26.9M 1.15%
+247,723
New +$24.2M
CBC
18
Central Bancompany Inc
CBC
$7.68B
$24M 1.03%
+993,879
New +$23.4M
KROS icon
19
Keros Therapeutics
KROS
$199M
$16.8M 0.72%
823,707
-1,884,511
-70% -$33.1M
SBGI icon
20
Sinclair Inc
SBGI
$974M
$13.9M 0.6%
+909,653
New +$13.5M
WK icon
21
Workiva
WK
$2.94B
$5.17M 0.22%
+59,946
New +$5.31M
FSP
22
Franklin Street Properties
FSP
$44.8M
$2.13M 0.09%
2,253,389
-326,968
-13% -$380K
SN icon
23
SharkNinja
SN
$21B
$688K 0.03%
6,152
AIV
24
Aimco
AIV
$380M
-3,617,314
Closed -$28.7M
NNI icon
25
Nelnet
NNI
$4.79B
-31,535
Closed -$3.95M

Similar funds

Madison Avenue Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Madison Avenue Partners held 28 positions worth $2.33B, up 39% from $1.68B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Madison Avenue Partners deployed $196M of net new capital in Q4 2025, opening 8 new positions and adding to 3 existing holdings. Its largest new stake was Solstice Advanced Materials: 2,782,460 shares worth $135M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Sandisk, an estimated $126M trimmed.

  • Madison Avenue Partners's largest Q4 2025 buy was Solstice Advanced Materials: 2,782,460 shares worth $135M.
  • Madison Avenue Partners added most to Markel Group in Q4 2025, an estimated $7.25M increase.
  • Madison Avenue Partners's biggest Q4 2025 reduction was Sandisk, cutting an estimated $126M.
  • Madison Avenue Partners fully exited News Corp Class A in Q4 2025, selling an estimated $44.6M.
  • Madison Avenue Partners's ten largest holdings make up 83% of its $2.33B portfolio in Q4 2025.
  • Madison Avenue Partners opened 8 new positions and closed 5 in Q4 2025.
  • Madison Avenue Partners's portfolio value rose 39% quarter-over-quarter to $2.33B.

Based on Madison Avenue Partners's 13F filing for Q4 2025, filed 17 Feb 2026.